Discovery may bolster chemotherapy potency while protecting the heart from side-effects

by University of Alberta Faculty of Medicine & Dentistry(From left) Researchers Gopinath Sutendra and Bruno Saleme in a lab at the University of Alberta. The two have found a new therapeutic

Updated on: April 14,2024

Discovery may bolster chemotherapy potency while protecting the heart from side-effects

by University of Alberta Faculty of Medicine & Dentistry(From left) Researchers Gopinath Sutendra and Bruno Saleme in a lab at the University of Alberta. The two have found a new therapeutic

Updated on:April 14,2024

A molecule that regulates the development of cancer in a variety of human tumors

by Dr. Sonia Guil,Josep Carreras Leukaemia Research InstituteThe main authors of the study, from left to right: Dr. Lourdes Farré, Dr. Sonia Guil and Ph.D. fellow Cristina Oliveira. Credit: Dr.

Updated on: May 17,2024

A molecule that regulates the development of cancer in a variety of human tumors

by Dr. Sonia Guil,Josep Carreras Leukaemia Research InstituteThe main authors of the study, from left to right: Dr. Lourdes Farré, Dr. Sonia Guil and Ph.D. fellow Cristina Oliveira. Credit: Dr.

Updated on:May 17,2024

Enhancing quality of life for brain tumor survivors

by Monique Mita,Griffith UniversityGriffith School of Applied Psychology Professor Tamara Ownsworth said the Tele-Mast program aims to enhance quality of life for brain tumor survivors. Credit:

Updated on: January 07,2024

Enhancing quality of life for brain tumor survivors

by Monique Mita,Griffith UniversityGriffith School of Applied Psychology Professor Tamara Ownsworth said the Tele-Mast program aims to enhance quality of life for brain tumor survivors. Credit:

Updated on:January 07,2024

'Cancer-blocking' protein offers potential to transform cells from destructive to constructive

byAustralian National UniversityNLRC4 attenuates tumor development inApcmin/+mice. Credit:Nature Immunology(2024). DOI: 10.1038/s41590-024-01988-6An immune protein could

Updated on: November 10,2024

'Cancer-blocking' protein offers potential to transform cells from destructive to constructive

byAustralian National UniversityNLRC4 attenuates tumor development inApcmin/+mice. Credit:Nature Immunology(2024). DOI: 10.1038/s41590-024-01988-6An immune protein could

Updated on:November 10,2024

Incidence of early-stage breast CA, CRC up with ACA adoption

(HealthDay)—After adoption of the Affordable Care Act (ACA), there was an increase in the incidence of early-stage breast and colorectal cancer, according to a research letter published online Nov. 2

Updated on: April 20,2024

Incidence of early-stage breast CA, CRC up with ACA adoption

(HealthDay)—After adoption of the Affordable Care Act (ACA), there was an increase in the incidence of early-stage breast and colorectal cancer, according to a research letter published online Nov. 2

Updated on:April 20,2024

Encyclopedic tumor analysis for guiding treatment of advanced, broadly refractory cancers

by OncotargetCONSORT diagram. Credit: Ajay SrinivasanRESILIENT was a single arm, open label, phase II/III study to test if label agnostic therapy regimens guided by Encyclopedic Tumor Analysis can off

Updated on: May 09,2024

Encyclopedic tumor analysis for guiding treatment of advanced, broadly refractory cancers

by OncotargetCONSORT diagram. Credit: Ajay SrinivasanRESILIENT was a single arm, open label, phase II/III study to test if label agnostic therapy regimens guided by Encyclopedic Tumor Analysis can off

Updated on:May 09,2024

'Junk DNA' no more: Investigators develop method of identifying cancers from repeat elements of genetic code

by Johns Hopkins University School of MedicineNew method called ARTEMIS uses machine learning to shed light on human genome "dark matter" involved in cancer and other diseases. Credit:

Updated on: March 20,2024

'Junk DNA' no more: Investigators develop method of identifying cancers from repeat elements of genetic code

by Johns Hopkins University School of MedicineNew method called ARTEMIS uses machine learning to shed light on human genome "dark matter" involved in cancer and other diseases. Credit:

Updated on:March 20,2024

Researchers pinpoint nongenetic mechanisms in lung cancer resistance to one commonly used therapy

by Katie Neith,City of Hope National Medical CenterCredit: Unsplash/CC0 Public DomainIn a recent study led by Ravi Salgia, M.D., Ph.D., the Arthur & Rosalie Kaplan Chair in Medical Oncology,

Updated on: June 01,2024

Researchers pinpoint nongenetic mechanisms in lung cancer resistance to one commonly used therapy

by Katie Neith,City of Hope National Medical CenterCredit: Unsplash/CC0 Public DomainIn a recent study led by Ravi Salgia, M.D., Ph.D., the Arthur & Rosalie Kaplan Chair in Medical Oncology,

Updated on:June 01,2024

Drugs for invasive breast cancer 'could treat earliest stages of the disease'

by Emma Thorne,University of NottinghamMicrograph showing a lymph node invaded by ductal breast carcinoma, with extension of the tumour beyond the lymph node. Credit: Nephron/WikipediaDrug

Updated on: April 10,2024

Drugs for invasive breast cancer 'could treat earliest stages of the disease'

by Emma Thorne,University of NottinghamMicrograph showing a lymph node invaded by ductal breast carcinoma, with extension of the tumour beyond the lymph node. Credit: Nephron/WikipediaDrug

Updated on:April 10,2024

Shedding light—literally—on resistance to radiation therapy

by Johns Hopkins UniversityCredit: CC0 Public DomainA new Johns Hopkins study offers promise towards someday being able to non-invasively examine changes in cancerous tumors to determine whether

Updated on: March 12,2024

Shedding light—literally—on resistance to radiation therapy

by Johns Hopkins UniversityCredit: CC0 Public DomainA new Johns Hopkins study offers promise towards someday being able to non-invasively examine changes in cancerous tumors to determine whether

Updated on:March 12,2024

Learning the language of cells to beat cancer

byThe Mount Sinai HospitalIdealized workflow utilizing multiomic tissue profiling for achieving personalized medicine. Workflow includes integration of scRNA-seq and ST along with other tissue p

Updated on: January 15,2024

Learning the language of cells to beat cancer

byThe Mount Sinai HospitalIdealized workflow utilizing multiomic tissue profiling for achieving personalized medicine. Workflow includes integration of scRNA-seq and ST along with other tissue p

Updated on:January 15,2024

Researchers discover link between PSA level at time of salvage therapy following surgery and risk of death

by Brigham and Women's HospitalAdjusted estimates of ACM among men illustrating the difference in these estimated among patients in the time-dependent treatment groups of no RT, aRT, salvage

Updated on: February 01,2024

Researchers discover link between PSA level at time of salvage therapy following surgery and risk of death

by Brigham and Women's HospitalAdjusted estimates of ACM among men illustrating the difference in these estimated among patients in the time-dependent treatment groups of no RT, aRT, salvage

Updated on:February 01,2024